PHD2 Constrains Antitumor CD8+ T-cell Activity.
Bisilliat Donnet C, Acolty V, Azouz A, Taquin A, Henin C, Trusso Cafarello S, Denanglaire S, Mazzone M, Oldenhove G, Leo O, Goriely S, Moser M.
Bisilliat Donnet C, et al. Among authors: leo o.
Cancer Immunol Res. 2023 Mar 1;11(3):339-350. doi: 10.1158/2326-6066.CIR-22-0099.
Cancer Immunol Res. 2023.
PMID: 36603132